Skip to Main Content

Author Details

Cary Oberije
Maastricht University Medical Centre
2005
67
35
PMIDPaper TitleJournal TitlePublished Year
36375562Cost-effectiveness of proton radiotherapy versus photon radiotherapy for non-small cell lung cancer patients: Exploring the model-based approach.Radiother Oncol2023
36359199Open Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology.Biomedicines2022
35584320Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?Clin Transl Gastroenterol2022
35535474Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision-making.Health Expect2022
34072509Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an <i>In Silico</i> Clinical Trial and a Cost-Utility Study.Cancers (Basel)2021
33919882Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape.J Pers Med2021
33857224Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.PLoS One2021
32539805Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.BMC Cancer2020
32101448Radiomics: from qualitative to quantitative imaging.Br J Radiol2020
32570638Implications of Clinicians' Attitudes Towards Clinical Decision Support Systems.Stud Health Technol Inform2020
32381298Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy.Semin Radiat Oncol2020
30730570Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)].Med Phys2019
31158263Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.PLoS One2019
29763967Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.Med Phys2018
29952681Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer.Acta Oncol2018
2949459818F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.PLoS One2018
26774327Decision support systems for personalized and participative radiation oncology.Adv Drug Deliv Rev2017
29594204Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCAT.Clin Transl Radiat Oncol2017
29122046MODEL-BASED COST-EFFECTIVENESS OF CONVENTIONAL AND INNOVATIVE CHEMO-RADIATION IN LUNG CANCER.Int J Technol Assess Health Care2017
28506693Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.Radiother Oncol2017
28871984Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.Int J Radiat Oncol Biol Phys2017
25732723Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity.Med Decis Making2016
26399389Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab.Acta Oncol2016
27139126Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation.Radiother Oncol2016
26867890Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys2016
25936599A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients.Int J Radiat Oncol Biol Phys2015
26395528Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine.Acta Oncol2015
25835622Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.Int J Radiat Oncol Biol Phys2015
24452446Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer.J Cachexia Sarcopenia Muscle2014
27201853Calibration And Statistical Modeling To Inform A Micro-Simulation Model For Early HTA.Value Health2014
25241994Rapid learning in practice: a lung cancer survival decision support system in routine patient care data.Radiother Oncol2014
24846083A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.Radiother Oncol2014
24861629Epigenetics in radiotherapy: where are we heading?Radiother Oncol2014
23993399'Rapid Learning health care in oncology' - an approach towards decision support systems enabling customised radiotherapy'.Radiother Oncol2013
24047338Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.Acta Oncol2013
24044794Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients.Radiother Oncol2013
24035329Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.Int J Radiat Oncol Biol Phys2013
22543884Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?Strahlenther Onkol2012
23127773No association between TGF-β1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients.Radiother Oncol2012
20884128[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.Int J Radiat Oncol Biol Phys2011
21784544Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients.Radiother Oncol2011
21605946Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy.Int J Radiat Oncol Biol Phys2011
20888135Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).Int J Radiat Oncol Biol Phys2011
19782478Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.Int J Radiat Oncol Biol Phys2010
21084125Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients.Radiother Oncol2010
20831492Prediction of residual metabolic activity after treatment in NSCLC patients.Acta Oncol2010
20443461Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy.Med Phys2010
20647155The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer.Radiother Oncol2010
18547458Modelling antecedents of blood donation motivation among non-donors of varying age and education.Br J Psychol2009
19576645Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.Radiother Oncol2009
  • 1 - 50 of 67

Recommended Authors

Hengrui Liang
The First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2017
Number of shared co-authors 0
Yi Zhao
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2013
Number of shared co-authors 0
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 0
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 0
Hanbo Chen
University of Toronto
Career Start Year 2010
Number of shared co-authors 5
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 1
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Steven H Lin
University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Career Start Year 2005
Number of shared co-authors 7
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 1
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 2
Fiona Blackhall
The University of Manchester
Career Start Year 2000
Number of shared co-authors 4
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 2
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 3
Betty C Tong
Duke University Medical Center
Career Start Year 1996
Number of shared co-authors 0
Ping Yang
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 0
Cheryl Ho
University of British Columbia
Career Start Year 1995
Number of shared co-authors 2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 4
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 4
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 4
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Gail Darling
University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1977
Number of shared co-authors 5
David H Harpole
Duke University Medical Center
Career Start Year 1962
Number of shared co-authors 0

Collaborators

Philippe Lambin
Maastricht University
Co-authored papers 54
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 34
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 20
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers 10
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 8
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 7
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 6
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers 6
Georgi Nalbantov
Department of Radiation Oncology (MAASTRO Clinic)
Co-authored papers 5
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 5
Kim M Smits
Maastricht University Medical Center+
Co-authored papers 5
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Co-authored papers 4
Ludwig Dubois
Maastricht University
Co-authored papers 4
David A Palma
University of Western Ontario
Co-authored papers 3
Erik Roelofs
Maastricht University Medical Centre+
Co-authored papers 3
Andrew Warner
Western University and London Regional Cancer Program
Co-authored papers 3
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Co-authored papers 2
Manon van Engeland
Maastricht University Medical Center
Co-authored papers 2
Veerle Melotte
Maastricht University Medical Center.
Co-authored papers 2
Johannes H A M Kaanders
Radboud University Medical Center
Co-authored papers 2
Ruud G P M van Stiphout
University of Oxford
Co-authored papers 2
David R Raleigh
University of California san francisco
Co-authored papers 2
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 2
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 1
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 1
An M Voets
Maastricht University Medical Centre
Co-authored papers 1
Coen R N Rasch
Leiden University Medical Center
Co-authored papers 1
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 1
Release 1.2